Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.
Sjögreen Gleisner K, Chouin N, Gabina PM, Cicone F, Gnesin S, Stokke C, Konijnenberg M, Cremonesi M, Verburg FA, Bernhardt P, Eberlein U, Gear J. Sjögreen Gleisner K, et al. Among authors: chouin n. Eur J Nucl Med Mol Imaging. 2022 May;49(6):1778-1809. doi: 10.1007/s00259-022-05727-7. Epub 2022 Mar 14. Eur J Nucl Med Mol Imaging. 2022. PMID: 35284969 Free PMC article.
The "reset button" revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients.
Verburg FA, Luster M, Giovanella L, Lassmann M, Chiesa C, Chouin N, Flux G; EANM Thyroid, Radiation Protection and Dosimetry Committees. Verburg FA, et al. Among authors: chouin n. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):915-917. doi: 10.1007/s00259-017-3649-9. Epub 2017 Feb 16. Eur J Nucl Med Mol Imaging. 2017. PMID: 28210770 No abstract available.
The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy.
Chiesa C, Sjogreen Gleisner K, Flux G, Gear J, Walrand S, Bacher K, Eberlein U, Visser EP, Chouin N, Ljungberg M, Bardiès M, Lassmann M, Strigari L, Konijnenberg MW. Chiesa C, et al. Among authors: chouin n. Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1783-1786. doi: 10.1007/s00259-017-3707-3. Epub 2017 May 24. Eur J Nucl Med Mol Imaging. 2017. PMID: 28536834 No abstract available.
From fixed activities to personalized treatments in radionuclide therapy: lost in translation?
Flux GD, Sjogreen Gleisner K, Chiesa C, Lassmann M, Chouin N, Gear J, Bardiès M, Walrand S, Bacher K, Eberlein U, Ljungberg M, Strigari L, Visser E, Konijnenberg MW. Flux GD, et al. Among authors: chouin n. Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):152-154. doi: 10.1007/s00259-017-3859-1. Epub 2017 Oct 27. Eur J Nucl Med Mol Imaging. 2018. PMID: 29080096 Free PMC article. No abstract available.
Re: Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma.
Walrand S, Chiesa C, Gabina PM, Chouin N, Gear J, Stokke C, Bernhardt P, Gleisner KS, Strigari L, Konijnenberg M; EANM Dosimetry Committee. Walrand S, et al. Among authors: chouin n. J Vasc Interv Radiol. 2019 Dec;30(12):2047-2048. doi: 10.1016/j.jvir.2019.08.030. Epub 2019 Oct 30. J Vasc Interv Radiol. 2019. PMID: 31676203 No abstract available.
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry.
Gabiña PM, Gleisner KS, Cremonesi M, Stokke C, Flux G, Cicone F, Konijnenberg M, Aldridge M, Sandstrom M, Chiesa C, Paphiti M, Hippeläinen E, Uribe C, Solny P, Gnesin S, Bernhardt P, Chouin N, Costa PF, Glatting G, Verburg F, Gear J. Gabiña PM, et al. Among authors: chouin n. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2595-2604. doi: 10.1007/s00259-023-06215-2. Eur J Nucl Med Mol Imaging. 2023. PMID: 37129712 No abstract available.
35 results